AZN vs MTCH · P/E 28, $288.38B cap vs P/E 13, rev $1.72B
AstraZeneca PLC (AZN) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the AZN and MTCH stock pages for the full models.
Not investment advice.